Data from the phase 3b STEP UP trial demonstrate that the 7.2 mg semaglutide dose provides superior weight reduction compared ...
This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Common semaglutide side effects include nausea, vomiting, ...
This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Semaglutide nausea is common: About 20 percent of Ozempic® ...
For many Americans struggling to lose weight, powerful new medications are changing the game. With roughly 40% of U.S. adults living with obesity, according to the Centers for Disease Control ...
Wegovy HD demonstrated a mean weight loss of 20.7%1, and around one-third of patients achieved 25% or greater weight loss in the STEP UP trialFirst US FDA approval of a GLP-1 treatment under the Commi ...
Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties from compounding the drug. Our FDA/Food, Drug & Device and ...
Rules determining who gets access to semaglutide in India were written for different bodies with different cardiovascular risks.
In the warning letter, the FDA alleged that Novo inadequately responded to observations made after an inspection carried out across January and February of 2025.
A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.
After the February Declaratory Order was issued, the Outsourcing Facilities Association (the “OFA”) promptly filed a lawsuit against the FDA over its decision and a motion for a preliminary injunction ...
Researchers found that the odds of developing an eye condition that leads to vision loss were about 5 times higher among ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results